🇪🇺 Fast delivery (3–5 working days) with GLS ✅ Card or bank transfer 📦 Free shipping from €50

Ipamorelin
Peptology Ltd. · Recovery and anabolic peptides
Ipamorelin 5/10 mg is a selective GH secretagogue (ghrelin receptor agonist, GHS-R1a), research peptide. Purity 99%+, HPLC/MS report for every batch.
📦 The product is in our EU warehouse – delivery within 3–5 working days.
30,00 € · In stock
For research use only / Not a medicine



| Purity | >99% |
|---|---|
| Method | HPLC + LC/MS |
| Laboratory | Analiza Białek |
| Batch | 0226 |
Ipamorelin is a synthetic pentapeptide and a selective growth hormone secretagogue (GHRP) — an agonist of the ghrelin receptor (GHS-R1a). It mimics the action of ghrelin and stimulates the pituitary to the natural, pulsatile secretion of growth hormone (GH). In the literature it is described as "the first selective GH secretagogue", because it raises GH virtually without affecting other hormones.
It is precisely selectivity that is the most important feature of Ipamorelin. In contrast to older GHRP peptides such as GHRP-2, GHRP-6 or Hexarelin, Ipamorelin does not significantly increase the level of cortisol, prolactin or appetite. This makes it one of the cleanest and best-tolerated compounds of this class in studies.
Ipamorelin acts on the GHS-R1a receptor — distinct from the GHRH receptor targeted by analogs such as CJC-1295 or Sermorelin. Because these are two independent pathways, in studies they are classically combined into a pair (GHRH analog + Ipamorelin) for a synergistic effect — hence the ready-made complex CJC-1295 + Ipamorelin.
Ipamorelin is studied in the context of the GH/IGF-1 axis, regeneration, sleep, body composition and lipolysis. It is a research peptide — it holds no authorization as a medicinal product. See also the other recovery and anabolic peptides in our category.
In the version offered by Peptology, Ipamorelin is supplied as a lyophilized peptide with purity above 99% (HPLC/MS), confirmed by independent laboratory analysis (CoA for every batch). It is available in two vial formats — 5 mg and 10 mg — depending on the scale of the research protocol.
Ipamorelin is available in two lyophilized formats that cover different scales of research work — from single in vitro series to longer GH-axis protocols with higher peptide consumption.
5 MG
Standard format
Suitable for validation experiments, single in vitro series and shorter GH-axis protocols.
10 MG
Enlarged format
For longer research series, schedules combined with a GHRH analog and protocols with higher peptide consumption.
Both formats have identical purity > 99% and the same laboratory certificate for the batch. The choice of size depends on the scale of the protocol, not on the concentration of the active substance.
In the research literature, Ipamorelin is described as a selective ghrelin receptor agonist that stimulates pulsatile GH secretion without disturbing the balance of other hormones. The three features below together explain its "clean" profile.
GHS-R1a RECEPTOR
Mimics ghrelin, activating the GHS-R1a receptor in the pituitary (the Gαq/11 → PLC → IP3 → Ca²⁺ pathway), which triggers GH secretion from somatotropic cells.
SELECTIVITY
Raises GH without a significant effect on cortisol, ACTH, prolactin and appetite — in contrast to GHRP-6, GHRP-2 or Hexarelin.
PULSATILE GH & SYNERGY
Produces a physiological GH pulse (peak ~40 min). Acts on a different receptor than GHRH, which is why combining it with a GHRH analog amplifies GH release.
Older GHRP secretagogues (GHRP-6, GHRP-2, Hexarelin) effectively raise GH, but at the same time activate pathways that increase cortisol, ACTH and prolactin, and some strongly stimulate appetite. Ipamorelin was designed to retain a strong effect on GH while eliminating these side effects — which is why it is described as the "cleanest" GHRP and is often chosen for the first research protocols.
Because the GHS-R1a (Ipamorelin) and GHRH (e.g. CJC-1295) pathways are independent, in studies a GHRH analog (background) is classically combined with Ipamorelin (pulse). This data comes from pharmacological studies and does not constitute a claim about the effect of the research-grade product.
Ipamorelin is a small pentapeptide, which in the published pharmacokinetic data is described as a molecule with a moderate half-life and a fast, pulsatile profile of action on the GH axis.
The table below compares three GHRP secretagogues acting on the same GHS-R1a receptor, but differing in selectivity and profile. Ipamorelin stands out for its "clean" action on GH, GHRP-2 is stronger but less selective, and Hexarelin is the strongest but with the greatest effect on cortisol/prolactin and a risk of desensitization. The data are scientific and comparative in nature.
| Ipamorelin | GHRP-2 | Hexarelin | |
|---|---|---|---|
| Class | Selective GHRP (GHS-R1a) | GHRP (GHS-R1a) | GHRP (GHS-R1a) |
| Effect on cortisol / prolactin | Minimal | Moderate | Highest |
| Appetite stimulation | Minimal | Marked | Moderate |
| GH release strength | High (selective) | Very high | Highest |
| Profile in studies | "Cleanest" GHRP, good tolerability | Strong, less selective | Strongest, desensitization risk |
The values are approximate and come from the pharmacological literature on GH secretagogues. The table is scientific and comparative in nature and does not constitute a direct head-to-head comparison or a claim about the effect of the research-grade product.
Ipamorelin was developed as a pharmaceutical candidate, but its clinical program was not carried through to registration. It remains a research molecule with a well-described pharmacological profile. Below are the most important observations from the literature.
In pharmacological studies, Ipamorelin was characterized as the first secretagogue producing strong, dose-dependent GH secretion without a simultaneous increase in ACTH and cortisol — which distinguishes it from earlier GHRP peptides. This selectivity is its most frequently cited feature.
In observations, Ipamorelin produces a marked GH pulse (peak ~40 min) and — with repeated use — an increase in GH/IGF-1 axis markers. This profile is consistent with physiological, pulsatile GH secretion, rather than a constant, elevated background.
In studies, the combination of Ipamorelin with a GHRH analog (like CJC-1295) is associated with stronger GH release than either component alone, because they act on separate receptors. A ready-made complex is available as CJC-1295 + Ipamorelin.
Note: The information is presented for scientific and informational purposes and is based on the pharmacological literature. It does not constitute medical advice, a recommendation for use or a claim about the effect of the research-grade product offered by Peptology.
All information provided refers to the pharmacological literature on Ipamorelin and should not be interpreted as a promise of effect, an instruction for use or a claim about the effect of the research-grade product offered by Peptology.
Important: The information below describes schedules used in research on Ipamorelin. It is provided for scientific and informational purposes and does not constitute a recommendation for individual use, medical advice or administration instructions. The research-grade Ipamorelin offered by Peptology is not a registered drug.
Due to its pulsatile profile, Ipamorelin is administered in studies subcutaneously, usually daily, often in combination with a GHRH analog:
In GH-axis protocols, Ipamorelin is classically combined with CJC-1295; a ready-made complex is CJC-1295 + Ipamorelin. These schedules come from the research literature and do not constitute a recommendation for self-administration.
Ipamorelin has one of the best safety profiles in the GHRP class. Side effects in observations are rare and mild, and the key advantage is the absence of an effect on cortisol, prolactin and appetite.
Frequently observed (mild)
Less frequently described
What is usually absent
Thanks to its selectivity and good tolerability, Ipamorelin is described in the literature as suitable for longer protocols. Due to the GH-dependent mechanism, glucose handling remains an important element of observation. This information is scientific in nature and does not constitute an instruction for use.
Ipamorelin is supplied as a lyophilized (freeze-dried) powder in a vial. In lyophilized form the peptide is stable at room temperature, protected from light and moisture — refrigeration before reconstitution is not mandatory. After reconstitution, stability depends on the solvent used, with Peptide Matrix Water™ significantly extending the peptide's lifespan.
Laboratory tip: With your order, you can add Peptide Matrix Water™ to the cart — a stabilizing solution designed for working with reconstituted research peptides. More in the article Bacteriostatic water vs acetic acid vs matrix water.
It is a synthetic pentapeptide and a selective ghrelin receptor agonist (GHS-R1a) that stimulates the pulsatile secretion of growth hormone from the pituitary. It stands out for not raising cortisol, prolactin or appetite. The results come from the pharmacological literature.
Ipamorelin raises GH with a minimal effect on cortisol and prolactin, whereas GHRP-2 and GHRP-6 also raise these hormones and more strongly stimulate appetite. That is why Ipamorelin is described as the most selective and best-tolerated in the GHRP class.
Yes — this is the classic research schedule. The GHRH analog (CJC-1295) provides the background, and Ipamorelin adds the GH pulse; they act on different receptors, so the effect is additive. A ready-made complex is CJC-1295 + Ipamorelin.
About 2 hours, with a GH peak ~40 minutes after administration and a return to baseline within ~3 hours. This justifies the daily, pulsatile administration schedule in protocols.
Both have identical purity > 99% and the same batch certificate. 5 mg works well for shorter protocols and single series, and 10 mg — for longer GH-axis studies and schedules combined with a GHRH analog.
The lyophilized vial is stored at room temperature, protected from light and moisture. After reconstitution, stability depends on the solvent: with Peptide Matrix Water™ — up to 60 days in the refrigerator +2 °C to +8 °C; with bacteriostatic or sterile water — up to 28 days. Avoid refreezing.
Peptology offers Ipamorelin (5 / 10 mg) as a research peptide with confirmed purity above 99% (HPLC/MS) and independent laboratory analysis for every batch. Fast shipping, discreet packaging and certificates of purity with the product. For scientific background, also see the article Peptides — what they are, how they work, main categories and safety profile.
Researchers working with Ipamorelin often also consider other GH-axis tools — GHRH analogs, GHRP secretagogues and ready-made complexes. Each of the products below has a certificate of purity above 99%:
CJC-1295 + Ipamorelin
Ready-made GHRH + GHRP complex
CJC-1295 without DAC
GHRH analog (a stack partner)
GHRP-2
A stronger, less selective GHRP
Hexarelin
The most potent GH secretagogue
Sermorelin
GHRH analog (GRF 1-29)
Peptide Matrix Water™
Stabilizing solution for reconstitution
See the full catalog: Recovery and anabolic peptides · Solutions for peptides · All peptides · Blog on peptide research
Research warning: Ipamorelin is offered exclusively for scientific research and in vitro purposes. It is not a medicinal product, is not approved for use in humans or animals, and does not replace medical advice. All information comes from the pharmacological and research literature and is provided for scientific and informational purposes; it does not constitute a claim about the effect of the research-grade product offered by Peptology.
Standardized protocol applicable to all research peptides in the Peptology catalogue. To calculate the solution concentration (mg/mL) for each vial, use the peptide reconstitution calculator.
1. SOLVENT
2. RECONSTITUTION
Add the solvent down the side of the vial, without shaking, wait 10–15 min.
3. CALCULATION
Calculator → concentration mg/mL
4. STORAGE
+2 °C to +8 °C, up to 60 days with Peptide Matrix Water
| Parameter | Value |
|---|---|
| Form | Lyophilized powder |
| Solvent | Peptide Matrix Water |
| Reconstitution volume | 1–3 mL — maximum 3 mL (capacity of the standard vial) |
| Storage before reconstitution | Room temperature, protected from direct light (refrigeration not required) |
| After reconstitution | Up to 60 days at +2 °C to +8 °C with Peptide Matrix Water |
Precision pipette
Calibrated, 100–1000 µL — for accurately measuring the volume of solvent added to the vial.
70% alcohol swabs
Two swabs — to disinfect the peptide vial and the solvent vial.
Stabilized solvent for lyophilized peptides. Why this one.
| ✅ Correct | ❌ Mistake |
|---|---|
| Disinfect the vial caps and the work surface with 70% alcohol; wear gloves | Working without disinfection |
| Add the solvent slowly along the vial wall | Direct jet onto the powder — foaming and denaturation |
| Gentle rolling between the palms | Shaking — foam, which denatures peptides |
| 10–15 minutes waiting at room temperature | Mechanical mixing or heating |
| Visual check: clear, particle-free | Working with a cloudy or discolored solution |
⚠️ Maximum 3 mL solvent. The standard vial does not accommodate larger volumes — do not exceed during reconstitution.
Reconstitution per vial — solvent: Peptide Matrix Water. Concentration after adding the solvent (1 mg/mL = 1 µg/µL):
| Vial | + 1 mL | + 2 mL | + 3 mL |
|---|---|---|---|
| 5 mg | 5 mg/mL | 2.5 mg/mL | 1.67 mg/mL |
| 10 mg | 10 mg/mL | 5 mg/mL | 3.33 mg/mL |
👉 For any vial and solvent volume — use the calculator. It calculates the concentration (mg/mL, µg/µL) and the volume per sample (mL, µL).
BEFORE RECONSTITUTION
Room temperature, protected from direct light, in original packaging. Refrigerator not required.
AFTER RECONSTITUTION
+2 °C to +8 °C, up to 60 days with Peptide Matrix Water. Discard any remainder after this period.
FREEZING
Not recommended. Freeze/thaw cycles degrade peptide structure.
1. Shaking "to dissolve faster"
Foam = denaturation. Only gentle rolling between the palms.
2. Inappropriate solvent
For peptide stability use only sterile, specially formulated solvent — recommended Peptide Matrix Water.
3. Ignoring slight turbidity
Not fully clear = the sample does not meet the criteria for use.
4. Taking it out of the refrigerator "for an hour–two"
Short exposures add up and compromise stability.
Research status: All Peptology products are intended for laboratory and research use only. They are not medicinal products, not approved for human or veterinary use and do not substitute medical advice. The described protocol is standard laboratory practice for working with lyophilized peptides.
Products in our warehouse – orders placed by 15:00 on working days are dispatched the same day, later orders on the next working day.
Delivery with GLS to your address in 3–5 working days.
Shipping costs €5 and is free from €50.
Ipamorelin increases GH with minimal effect on cortisol and prolactin, whereas GHRP‑6/2 also affect those hormones.
It is supplied as a lyophilized (freeze-dried) powder in a sealed vial. Store the unopened vial dry and protected from light, ideally at 2–8 °C. After laboratory reconstitution, keep the solution at 2–8 °C and use it within the period stated in the “Laboratory reconstitution” tab (up to 60 days with Peptide Matrix Water).
Every batch has a purity of 99% or higher, confirmed by HPLC and mass spectrometry (MS) and documented in a certificate of analysis (CoA). The report for the current batch is shown in the “Laboratory Analysis” tab.
You can buy Ipamorelin in Europe online from Peptology, from 30,00 €. Delivery with GLS in 3–5 working days. Shipping is free from 50,00 €. Payment by card. Purity 99%+, with an HPLC report for every batch.

